Rare Diseases: Clinical Trials

590 trials for Rare Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

353 completed, 85 recruiting, 76 unknown, 26 terminated. 144 Not applicable, 117 Phase 2, 69 Phase 3, 53 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable144Completed 105, Recruiting 14, Unknown 13, Terminated 6, Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 2117Completed 87, Unknown 10, Recruiting 7, Active not recruiting 5, Terminated 4, Suspended 2, Not yet recruiting 1, Withdrawn 1
Phase 369Completed 56, Terminated 6, Unknown 4, Recruiting 2, Active not recruiting 1
Phase 153Completed 38, Unknown 5, Recruiting 4, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 46Completed 2, Recruiting 2, Unknown 1, Withdrawn 1
Early Phase 12Recruiting 1, Terminated 1

Follow Rare Diseases: new trials by email Literature Review of Rare Diseases trials Research Report on Rare Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Exercise and Lifestyle Programme for Adults With Vascular Ehlers-Danlos Syndrome: A Feasibility Study
Co-designed exercise-based lifestyle intervention - Vascular Ehlers Danlos Syndrome
Not applicableNot yet recruitingSheffield Hallam University402027-03-012026-07-13
An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)
S-606001, ERT - Pompe Disease
Phase 2Not yet recruitingShionogi602026-11-022026-10-13
Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France
Genetic and Inflammatory Polyneuropathies
Not yet recruitingAssistance Publique - Hôpitaux de Paris10002026-11-012026-10-01
A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia
Spinal Muscular Atrophy
Not yet recruitingNovartis Pharmaceuticals62026-11-012026-10-15
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
Undiagnosed Diseases, Rare Diseases
RecruitingNational Human Genome Research Institute (NHGRI)4002026-10-272026-10-22
EpiSign International: Expanding Epigenomic Testing in Rare Disease
Integrated EPIC/CNV microarray with EpiSign analysis, EpiSign analysis with EPIC DNA methylation microarray - Rare Disease, Undiagnosed Disease
Not yet recruitingUniversity of Manchester1922026-10-012026-09-24
Impact of Ultra-fast Genetic Diagnosis of Familial Lymphohistiocytosis on the Time to Bone Marrow Transplantation and Overall Survival
Third-generation sequencing - Familial Lymphohistiocytosis, Lymphohistiocytosis
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille2402026-10-012026-08-03
A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)
S-606001 - Pompe Disease
Phase 1Not yet recruitingShionogi152026-09-302026-08-26
Implementation-effectiveness Trial of Mainstreaming of Clinical Genomic Sequencing for Rare Disease in Ontario, Canada
Genome-wide Sequencing Ordering - Evaluation of Mainstreamed Models of Genetic Service Delivery, Genetic Disease
Not yet recruitingThe Hospital for Sick Children1002026-09-012026-09-02
Quality of Life in Adults With Untreated Fabry Disease in Sweden (QoLUF)
Qualitative Interview - Fabry Disease
Enrolling by invitationVastra Gotaland Region352026-08-212026-08-27
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
Pegcetacoplan - C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Phase 4RecruitingSwedish Orphan Biovitrum1502026-08-052026-09-09
AI-assisted Rare Disease Diagnosis
AI system - Rare Disorders, Rare Diseases
Not applicableRecruitingPeking Union Medical College Hospital10562026-08-012026-10-13
Digital Outcome Assessment Using AI Active Gaming and Motion Capture in Friedreich Ataxia
Laboratory validation session (VSimulator), Home-based active gaming assessment - Friedreich Ataxia
Not yet recruitingUniversity of Exeter402026-07-302026-07-28
Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
Elafibranor - Pregnancy Related
RecruitingIpsen32026-07-292026-10-06
The Mayo Clinic Rare and Undiagnosed Disease Hackathon
Undiagnosed Diseases, Genetic Diseases
Enrolling by invitationMayo Clinic502026-07-242026-10-01
Stakeholders of Rare Diseases Informing Values In Neuroethics
Rare Disorder, Disorder, Neurologic
RecruitingSt. Jude Children's Research Hospital3852026-07-082026-07-13
Artificial Intelligence for General and Rare Disease Diagnosis
AI-Assisted Diagnosis - Rare Disorders, Rare Diseases
Not applicableCompletedPeking Union Medical College Hospital2432026-06-102026-10-14
Identification of Cellular Biomarkers of Rare Eye Diseases in Adults
Ophthalmological visit, Questionnaires, Blood sample collection - Rare Diseases, Ophthalmology
Not applicableRecruitingInstitut National de la Santé Et de la Recherche Médicale, France1102026-06-012026-07-07
Implementing Dynamic Consent for Rare Disease Patients
Online consenting - Rare Disorders
Not yet recruitingIstituto Ortopedico Rizzoli502026-06-012026-04-22
Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome
CTH120, CTH120 placebo hard capsules - Fragile X Syndrome (FXS), Fragile X Syndrome
Phase 2RecruitingConnecta Therapeutics, S.L.302026-05-212026-07-17

Showing 20 of 590. Sign in to see all of them.

Narrower conditions

Genetic Diseases, Inborn (94)  ·  Neurologic Manifestations (73)  ·  Mental Disorders (71)  ·  Respiratory Tract Diseases (50)  ·  Communicable Diseases (48)  ·  Immune System Diseases (48)  ·  Metabolism, Inborn Errors (42)  ·  Endocrine System Diseases (34)  ·  Hematologic Diseases (34)  ·  Connective Tissue Diseases (29)  ·  Arthritis (26)  ·  Cystic Fibrosis (21)  ·  Gastrointestinal Diseases (17)  ·  Urogenital Diseases (17)

Broader conditions

Disease Attributes (590)  ·  Pathologic Processes (590)  ·  Pathological Conditions, Signs and Symptoms (590)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (276)  ·  Nervous System Diseases (192)  ·  Genetic Diseases, Inborn (154)  ·  Nutritional and Metabolic Diseases (151)  ·  Metabolic Diseases (135)  ·  Central Nervous System Diseases (116)  ·  Signs and Symptoms (110)  ·  Brain Diseases (101)  ·  Skin and Connective Tissue Diseases (101)  ·  Musculoskeletal Diseases (82)  ·  Hemic and Lymphatic Diseases (65)  ·  Immune System Diseases (62)

Interventions

Cyclophosphamide (17)  ·  Filgrastim (12)  ·  Antilymphocyte Serum (10)  ·  Methylprednisolone (9)  ·  Prednisone (8)  ·  Cyclosporine (7)  ·  Immunoglobulins (7)  ·  Leuprolide (7)  ·  Growth Hormone (6)  ·  Methotrexate (6)  ·  Surveys and Questionnaires (6)  ·  tin mesoporphyrin (6)  ·  Cysteamine (5)  ·  Ursodeoxycholic Acid (5)  ·  Acyclovir (4)

Sponsors

National Center for Research Resources (NCRR) (164)  ·  FDA Office of Orphan Products Development (20)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (13)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (13)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (13)  ·  University Hospital Tuebingen (13)  ·  Assistance Publique - Hôpitaux de Paris (10)  ·  IRCCS Policlinico S. Donato (10)  ·  Fairview University Medical Center (7)  ·  Institut National de la Santé Et de la Recherche Médicale, France (7)  ·  National Human Genome Research Institute (NHGRI) (7)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Icahn School of Medicine at Mount Sinai (6)  ·  Imagine Institute (6)  ·  Amgen (5)

Countries

United States (244)  ·  France (59)  ·  Italy (51)  ·  Germany (40)  ·  United Kingdom (25)  ·  Canada (22)  ·  Spain (21)  ·  Netherlands (15)  ·  Australia (11)  ·  China (11)  ·  Belgium (9)  ·  Israel (9)  ·  Switzerland (8)  ·  Austria (7)  ·  Brazil (7)

Top investigators

Karl Elmo Anderson (7)  ·  Richard J. Whitley (4)  ·  Rosalind Ramsey-Goldman (4)  ·  Alessandro Pini, MD (3)  ·  Bruce Barshop (3)  ·  Catherine A. Leitch (3)  ·  Dana S. Hardin (3)  ·  Gary L. Robertson (3)  ·  Horacio Kaufmann (3)  ·  Jerry R. Mendell (3)  ·  K. Scott Baker (3)  ·  Massimo Federico, MD (3)  ·  Pinchas Cohen (3)

Results publications

PMID 30467742, PMID 37415957, PMID 28899825, PMID 32063397, PMID 32573764, PMID 33874971, PMID 10655252, PMID 11113214, PMID 11114637, PMID 11535445, PMID 12183720, PMID 12393404, PMID 12490682, PMID 12795371, PMID 12885347, PMID 12885750, PMID 12966125, PMID 15564716, PMID 15602505, PMID 15666063, PMID 15817019, PMID 15936729, PMID 16212446, PMID 16685181, PMID 17262855, PMID 17538176, PMID 17699247, PMID 17873417, PMID 17947042, PMID 18417336, PMID 18851928, PMID 19524577, PMID 19652063, PMID 19680671, PMID 19933766, PMID 20131296, PMID 20164459, PMID 20350831, PMID 20427647, PMID 20524979, PMID 20605905, PMID 20709904, PMID 20716238, PMID 20829370, PMID 20955402, PMID 21163445, PMID 21173013, PMID 21259015, PMID 21865579, PMID 21917992

NIH funding

2025 (4), 2023 (3), 2015 (2), 2017 (2), 2019 (2), 2018 (1), K07MH001197 (1), P01DK058327 (1), P01HL059407 (1), R01DK042822 (1), R01DK043690 (1), R01DK043858 (1), R01DK047112 (1), R01DK049368 (1), R01DK049524 (1)